Skip to the main content.
Facebook Instagram Linkedin X YouTube Medium

megamenu-services

 

Turn Vision into Velocity with the Innovation CRO

Traditional CROs fragment device development with costly hand-offs and learning curves. Veranex unites the essential disciplines for medical device & diagnostic development under one roof from sketch to evidence-generation to market launch.

All connected. All aligned. All accelerating your path to market—delivering breakthrough devices and diagnostics that improve patient lives sooner.

Explore our Services

megamenu-solutions-expertise

 

Outcome-Driven Solutions for Medtech Challenges

Breakthrough innovation requires more than great solutions; it demands deep expertise and insight. Veranex packages outcome-driven solutions with 25+ years of specialized knowledge across major medtech categories, delivering integrated capabilities that solve your most pressing challenges faster and with greater certainty.

Purpose-built solutions. Proven results. User & Patient-centered innovation.

 

Solutions

Expertise

megamenu-company-2

 

Purpose-Built for Breakthroughs

Whether you're transforming patient care or disrupting entire therapeutic categories, innovation requires more than great science, it demands velocity.  Veranex was founded to bridge the gap between visionary concepts and market reality, combining proven expertise with agile execution to accelerate the innovations that matter most.  

We are the Innovation CRO.

Legacy of excellence. Proven execution. Patient impact accelerated.

 

Explore our Company

Study by Veranex and Alcon Highlights Time Efficiencies for Femtosecond Laser-Assisted Cataract Surgery

Veranex : Mar 24, 2025 10:23:06 PM

Commercialization

Veranex’s Commercial Strategy team partnered with Alcon in 2020 to design and execute a time-and-motion study comparing Alcon’s femtosecond laser system against a competitor. The goal of this study was to compare time efficiencies between the two systems, as cataract surgery is an extremely high-volume procedure. This study expanded to multiple sites and was accepted for publication in the Journal of Refractive Cataract Surgery in 2023.

Read the Article

Recent Study Co-authored by Veranex Researchers collaborating with a leading U.S. Ophthalmology Practice Highlights Real-World Workflow Efficiencies of Cloud-based Surgical Planning Software in Catara

Gary Keeler : Mar 24, 2025 10:22:45 PM

A research team led by Veranex researchers and a leading U.S, ophthalmology practice recently published results from a real-world time-and-motion...

Commercialization
Read More

Recent Study Co-authored by Veranex Staff Highlights Cost-effectiveness of Home Non-invasive Ventilation in Patients with Chronic Obstructive Pulmonary Disease (COPD) in the United Kingdom

admin.veranex : Mar 24, 2025 10:23:08 PM

By developing a cost-effectiveness model and associated manuscript for home non-invasive ventilation in patients with persistent hypercapnia after...

Commercialization
Read More

One Minute With the Expert

admin.veranex : Mar 24, 2025 10:22:49 PM

We sat down with Dr. Olivier Chevènement, DVM, PhD, Veterinary Surgeon and Study Director at Veranex to discuss comparative anatomy of the...

Read More